CD34(+) progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg(null) mice
SourceOncoimmunology, vol. 10, 1, (2021), article 1981049
Article / Letter to the editor
Display more detailsDisplay less details
vol. vol. 10
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.